查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2089093

神經復健設備市場：2026-2032年全球市場預測（按設備類型、年齡層、應用程式和最終用戶分類）

Neurorehabilitation Devices Market by Device Type, Age Group, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，神經復健設備市場規模將達到 26.2 億美元，複合年成長率為 7.98%。

主要市場統計數據
基準年 2025 15.3億美元
預計年份：2026年 16.6億美元
預測年份：2032年 26.2億美元
複合年成長率 (%) 7.98%

神經復健設備市場概覽

神經復健設備市場正從以設備為中心的治療模式轉向互聯、可衡量和個人化的復健模式。這項需求的驅動力是日益沉重的神經系統疾病負擔。世界衛生組織支持的一項發表在《柳葉刀神經病學》的研究估計，2021年全球有超過30億人患有某種形式的神經系統疾病，世衛組織預測，到2050年，60歲及以上人口將達到21億。

神經復健領域的變革性變化

神經復健設備領域正受到三大相互關聯的變革的影響而發生重塑：醫療服務的去中心化、基於療效的採購以及技術的融合。復健不再局限於住院或門診病人治療，隨著穿戴式感測器、遠距復健平台和雲端控制面板等技術的普及，居家復健和混合式神經復健模式正在不斷發展，大規模的指導性治療得以實現。

人工智慧的累積影響

人工智慧 (AI) 透過提升評估、個人化和工作流程效率，對神經復健設備整體產生著累積的影響。 AI 驅動的變異性分析利用來自穿戴式裝置、攝影機、機器人平台和連網治療系統的數據，幫助量化損傷程度、檢測補償運動並監測復健進展。

關鍵區域洞察

亞太地區在神經復健設備方面潛力巨大，中國、日本、印度、韓國、澳洲和東協國家都在加大對醫院現代化、老年護理基礎設施、數位醫療和本土醫療技術能力的投入。日本的超老化社會、韓國先進的機器人生態系統、中國不斷完善的醫院基礎設施以及澳洲系統化的復健路徑，都在推動復健機器人、穿戴式監測設備、虛擬實境療法和互聯神經復健平台的應用。隨著中風治療服務、神經病學和復健網路的持續發展，印度和東南亞市場也蘊藏著長期的、主導的機會。

關鍵小組洞察

隨著都市區醫院系統不斷提升神經復健能力，以及各國政府將非傳染性疾病管理、中風治療和數位醫療基礎設施列為優先事項，東協市場正變得日益具有吸引力。在海灣合作理事會（GCC）國家，先進的復健醫院、醫療旅遊和技術驅動型醫療正受到重視，這催生了對機器人復健系統、虛擬實境療法、遠端監控平台和先進神經復健設備的需求。

主要國家概況

美國擁有先進的復健醫院、大學附屬醫院以及大規模的中風和腦損傷護理體系，在神經復健設備的創新、臨床試驗、監管申報和商業化方面處於主導。加拿大則強調實證應用、互聯互通的醫療服務以及在省級醫療保健系統中普及復健服務。墨西哥和巴西正透過私營部門推動復健服務和神經科服務的擴張，其中巴西尤其具有拉丁美洲最大的商業機遇，這得益於其完善的醫院基礎設施以及對中風後和神經退化性疾病康復的巨大需求。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的神經復健解決方案，這些方案能夠減輕治療師的負擔，提高治療頻率，並產生可衡量的功能性療效。產品藍圖不僅應涵蓋儀器效能，還應包括軟體分析、安全的資料基礎設施、遠端監測、病人參與工具，以及在條件允許的情況下與電子健康記錄的互通性。

調查方法

本執行摘要採用結構化的二手調查方法編寫，並遵循既定的產業研究標準。研究資訊包括世界衛生組織公共衛生數據、經同儕審查的神經系統疾病負擔的研究、醫療設備監管文件、臨床復健文獻、產品類型分析、保險報銷趨勢、人口統計指標以及區域醫療基礎設施的實證數據。

結論

神經復健設備正成為應對全球神經系統疾病致殘負擔的重要工具。推動這一市場發展的因素包括人口老化、中風和神經退化性疾病發病率上升、康復領域人員短缺以及對客觀、數據驅動的康復結果的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 神經復健設備市場：依設備類型分類

  • 生物回饋療法系統
    • 肌電生物回饋療法
    • 壓力生物回饋療法
  • 外骨骼
    • 下肢
    • 上肢
  • 功能性電刺激設備
    • 嵌入式
    • 表面類型
  • 神經控制裝置
    • 侵襲型
    • 非侵入性
  • 虛擬實境系統

第8章：神經復健設備市場：依年齡層別分類

  • 成人
  • 老年人
  • 兒童

第9章：神經復健設備市場：依應用分類

  • 腦性麻痹
    • 共濟失調
    • 運動障礙
    • 痙攣
  • 多發性硬化症
    • 進行性
    • 復發緩解型
  • 帕金森氏症
    • 晚期
    • 初期
  • 脊髓損傷
  • 中風
    • 出血性
    • 缺血性

第10章：神經復健設備市場：依最終用戶分類

  • 診所
  • 居家醫療
  • 醫院
  • 復健中心
  • 研究機構

第11章 神經復健設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 神經復健設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 神經復健設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Abbott Laboratories
  • ANT Neuro BV
  • Bioness, Inc.
  • BioXtreme Robotics Rehabilitation
  • Boston Scientific Corporation
  • BTS Bioengineering SpA
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • Hasomed GmbH
  • Hocoma AG
  • Kinova Inc.
  • Medtronic plc
  • Myomo, Inc.
  • NeuroStyle Pte Ltd
  • ReWalk Robotics Ltd.
  • Tyromotion GmbH
  • Vibrant Ltd.
Product Code: MRR-710B1F0AC5A5

The Neurorehabilitation Devices Market is projected to grow by USD 2.62 billion at a CAGR of 7.98% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.53 billion
Estimated Year [2026] USD 1.66 billion
Forecast Year [2032] USD 2.62 billion
CAGR (%) 7.98%

Neurorehabilitation Devices Market Introduction

The neurorehabilitation devices market is moving from equipment-centered therapy toward connected, measurable, and patient-specific rehabilitation. Demand is supported by a large and growing neurological disease burden: WHO-backed research published in The Lancet Neurology estimated that more than 3 billion people were living with a neurological condition in 2021, while WHO notes that the population aged 60 years and older is expected to reach 2.1 billion by 2050.

This creates sustained need for robotic rehabilitation systems, functional electrical stimulation devices, wearable gait and motion sensors, virtual reality therapy, neurostimulation platforms, and brain-computer interface-enabled solutions. Providers and payers are prioritizing technologies that improve therapy intensity, document functional outcomes, support remote patient monitoring, and extend rehabilitation beyond specialist centers for stroke, spinal cord injury, traumatic brain injury, Parkinson's disease, multiple sclerosis, and cerebral palsy.

Transformative Shifts in Neurorehabilitation

The neurorehabilitation devices landscape is being reshaped by three connected shifts: decentralization of care, outcome-based procurement, and technology convergence. Rehabilitation is no longer limited to inpatient and outpatient clinics; home-based and hybrid neurorehabilitation models are expanding as wearable sensors, telerehabilitation platforms, and cloud dashboards enable supervised therapy at scale.

At the same time, hospitals and rehabilitation networks are seeking devices that generate objective evidence on gait, balance, range of motion, spasticity, upper-limb function, and therapy adherence. Robotics, virtual reality rehabilitation, functional electrical stimulation, non-invasive brain stimulation, digital therapeutics, and assistive technologies are increasingly integrated into multidisciplinary care pathways for stroke recovery, spinal cord injury rehabilitation, traumatic brain injury care, multiple sclerosis management, cerebral palsy therapy, and Parkinson's disease rehabilitation.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across neurorehabilitation devices by improving assessment, personalization, and workflow efficiency. AI-enabled motion analysis can help quantify impairment, detect compensatory movement, and monitor progress using data from wearables, cameras, robotic platforms, and connected therapy systems.

The most valuable AI applications are emerging where algorithms support clinicians rather than replace them. Adaptive rehabilitation robotics can adjust assistance levels, digital platforms can recommend therapy progression based on patient performance, and predictive analytics can identify adherence risks. Adoption depends on clinical validation, transparent model governance, cybersecurity, interoperability, and compliance with evolving medical device regulations for software-driven and connected rehabilitation technologies.

Key Regional Insights

Asia-Pacific is a high-potential region for neurorehabilitation devices as China, Japan, India, South Korea, Australia, and ASEAN countries invest in hospital modernization, aging-care infrastructure, digital health, and domestic medical technology capacity. Japan's super-aged population, South Korea's advanced robotics ecosystem, China's expanding hospital infrastructure, and Australia's structured rehabilitation pathways support adoption of rehabilitation robotics, wearable monitoring, virtual reality therapy, and connected neurorehabilitation platforms. India and Southeast Asian markets offer long-term access-driven opportunities as stroke services, neurology departments, and rehabilitation networks continue to develop.

North America remains a leading commercialization region due to strong rehabilitation networks, FDA-regulated device pathways, payer attention to functional outcomes, and active investment in digital health and connected care. Europe benefits from universal healthcare systems, rehabilitation research networks, clinical evidence standards, and MDR-driven quality expectations, with adoption supported by aging populations and established neurorehabilitation services. Latin America is improving access through private hospital groups, public neurology programs, and rising awareness of post-stroke rehabilitation, while the Middle East is investing in specialty rehabilitation centers, advanced hospitals, and medical tourism. Africa remains underpenetrated but has rising need for cost-effective, portable, durable, and training-light neurorehabilitation technologies that can address workforce and infrastructure constraints.

Key Group Insights

ASEAN markets are becoming more attractive as urban hospital systems expand neurorehabilitation capacity and governments emphasize noncommunicable disease management, stroke care, and digital health infrastructure. The GCC is prioritizing advanced rehabilitation hospitals, medical tourism, and technology-enabled care, creating opportunities for robotic rehabilitation systems, virtual reality therapy, remote monitoring platforms, and high-acuity neurorehabilitation equipment.

The European Union is important for evidence-led adoption, regulatory rigor, patient safety requirements, and cross-border research collaboration in neurorehabilitation devices. BRICS countries offer scale, local manufacturing potential, and rising neurological care demand, although reimbursement, specialist availability, and access to rehabilitation services vary widely. G7 markets remain central to premium device adoption, clinical validation, reimbursement innovation, and hospital-led digital transformation. NATO countries also show demand linked to trauma rehabilitation, veteran care, spinal cord injury treatment, brain injury recovery, and advanced assistive technologies for functional recovery.

Key Country Insights

The United States leads in neurorehabilitation device innovation, clinical trials, regulatory submissions, and commercialization, supported by advanced rehabilitation hospitals, academic medical centers, and a large stroke and brain injury care base. Canada emphasizes evidence-based adoption, connected care, and rehabilitation access across provincial healthcare systems. Mexico and Brazil are expanding private-sector rehabilitation access and neurology services, with Brazil representing the largest opportunity in Latin America due to its broad hospital base and high demand for post-stroke and neurodegenerative rehabilitation.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine aging demographics with established neurorehabilitation services, national health systems, and growing interest in digital rehabilitation tools; Germany is especially strong in engineering-led rehabilitation technology and clinical adoption of advanced medical devices. Russia maintains demand across large neurology and rehabilitation networks but faces procurement complexity and regional access variation. In Asia-Pacific, China is scaling hospital investment and domestic medtech development, India offers long-term access-driven growth as rehabilitation capacity expands, Japan and South Korea support robotics, sensor-enabled therapy, and aging-care solutions, and Australia benefits from structured rehabilitation pathways, digital health readiness, and established clinical governance for assistive and therapeutic technologies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated neurorehabilitation solutions that reduce therapist burden, increase therapy dosage, and generate measurable functional outcomes. Product roadmaps should combine device performance with software analytics, secure data infrastructure, remote monitoring, patient engagement tools, and interoperability with electronic health records where feasible.

Commercial strategy should be localized by reimbursement maturity, care setting, workforce availability, and infrastructure readiness. Premium robotic rehabilitation systems may fit advanced hospitals and specialty centers, while portable functional electrical stimulation devices, sensor-based assessment tools, wearable monitoring, and telerehabilitation platforms may scale faster in access-constrained markets. Partnerships with rehabilitation networks, universities, payers, public health systems, and patient advocacy groups can accelerate clinical evidence generation, clinician training, and adoption.

Research Methodology

This executive summary is developed using a structured secondary-research methodology aligned with established industry research standards. Inputs include public health data from WHO and peer-reviewed neurological burden research, medical device regulatory references, clinical rehabilitation literature, product category analysis, reimbursement signals, demographic indicators, and regional healthcare infrastructure evidence.

Insights are triangulated across disease burden, aging trends, technology maturity, regulatory direction, procurement behavior, reimbursement readiness, and care-delivery models. The analysis focuses on verified, data-backed market drivers rather than speculative forecasts, with emphasis on practical implications for manufacturers, investors, providers, policymakers, and strategic decision-makers in neurorehabilitation devices.

Conclusion

Neurorehabilitation devices are becoming essential tools for addressing the global neurological disability burden. The market is supported by aging populations, rising prevalence of stroke and neurodegenerative conditions, workforce constraints in therapy, and demand for objective, data-driven rehabilitation outcomes.

Future leadership will depend on clinical proof, usability, affordability, AI governance, cybersecurity, interoperability, and the ability to integrate devices into real care pathways across hospitals, outpatient centers, and home-based rehabilitation. Organizations that combine therapeutic efficacy with scalable digital infrastructure and region-specific commercialization models will be best positioned to support long-term growth in neurorehabilitation devices.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Neurorehabilitation Devices Market, by Device Type

  • 7.1. Biofeedback System
    • 7.1.1. EMG Biofeedback
    • 7.1.2. Pressure Biofeedback
  • 7.2. Exoskeleton
    • 7.2.1. Lower Limb
    • 7.2.2. Upper Limb
  • 7.3. Functional Electrical Stimulation Device
    • 7.3.1. Implantable
    • 7.3.2. Surface
  • 7.4. Neuromodulation Device
    • 7.4.1. Invasive
    • 7.4.2. Noninvasive
  • 7.5. Virtual Reality System

8. Neurorehabilitation Devices Market, by Age Group

  • 8.1. Adult
  • 8.2. Geriatric
  • 8.3. Pediatric

9. Neurorehabilitation Devices Market, by Application

  • 9.1. Cerebral Palsy
    • 9.1.1. Ataxic
    • 9.1.2. Dyskinetic
    • 9.1.3. Spastic
  • 9.2. Multiple Sclerosis
    • 9.2.1. Progressive
    • 9.2.2. Relapsing Remitting
  • 9.3. Parkinson's Disease
    • 9.3.1. Advanced Stage
    • 9.3.2. Early Stage
  • 9.4. Spinal Cord Injury
  • 9.5. Stroke
    • 9.5.1. Hemorrhagic
    • 9.5.2. Ischemic

10. Neurorehabilitation Devices Market, by End User

  • 10.1. Clinics
  • 10.2. Home Care
  • 10.3. Hospitals
  • 10.4. Rehabilitation Centers
  • 10.5. Research Institutes

11. Neurorehabilitation Devices Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Neurorehabilitation Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Neurorehabilitation Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Abbott Laboratories
  • 15.2. ANT Neuro B.V.
  • 15.3. Bioness, Inc.
  • 15.4. BioXtreme Robotics Rehabilitation
  • 15.5. Boston Scientific Corporation
  • 15.6. BTS Bioengineering S.p.A.
  • 15.7. Cyberdyne Inc.
  • 15.8. Ekso Bionics Holdings, Inc.
  • 15.9. Hasomed GmbH
  • 15.10. Hocoma AG
  • 15.11. Kinova Inc.
  • 15.12. Medtronic plc
  • 15.13. Myomo, Inc.
  • 15.14. NeuroStyle Pte Ltd
  • 15.15. ReWalk Robotics Ltd.
  • 15.16. Tyromotion GmbH
  • 15.17. Vibrant Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROREHABILITATION DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NEUROREHABILITATION DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NEUROREHABILITATION DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NEUROREHABILITATION DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROREHABILITATION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL NEUROREHABILITATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOFEEDBACK SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOFEEDBACK SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOFEEDBACK SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EMG BIOFEEDBACK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EMG BIOFEEDBACK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EMG BIOFEEDBACK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PRESSURE BIOFEEDBACK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PRESSURE BIOFEEDBACK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PRESSURE BIOFEEDBACK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EXOSKELETON MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXOSKELETON MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LOWER LIMB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LOWER LIMB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LOWER LIMB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL UPPER LIMB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL UPPER LIMB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL UPPER LIMB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FUNCTIONAL ELECTRICAL STIMULATION DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FUNCTIONAL ELECTRICAL STIMULATION DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FUNCTIONAL ELECTRICAL STIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IMPLANTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IMPLANTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IMPLANTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURFACE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURFACE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURFACE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROMODULATION DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROMODULATION DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROMODULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NONINVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NONINVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NONINVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VIRTUAL REALITY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VIRTUAL REALITY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VIRTUAL REALITY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CEREBRAL PALSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CEREBRAL PALSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CEREBRAL PALSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ATAXIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ATAXIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ATAXIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DYSKINETIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DYSKINETIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DYSKINETIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SPASTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SPASTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SPASTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PROGRESSIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PROGRESSIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PROGRESSIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RELAPSING REMITTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RELAPSING REMITTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RELAPSING REMITTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PARKINSON'S DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PARKINSON'S DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ADVANCED STAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ADVANCED STAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ADVANCED STAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL EARLY STAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL EARLY STAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL EARLY STAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SPINAL CORD INJURY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SPINAL CORD INJURY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SPINAL CORD INJURY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEMORRHAGIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HEMORRHAGIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEMORRHAGIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ISCHEMIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ISCHEMIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ISCHEMIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. GCC NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 207. GCC NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 208. GCC NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 211. GCC NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. GCC NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 214. GCC NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 215. GCC NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 216. GCC NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. G7 NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. G7 NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 246. G7 NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 247. G7 NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 248. G7 NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 249. G7 NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. G7 NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. G7 NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 252. G7 NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 253. G7 NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 254. G7 NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 255. G7 NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. NATO NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. NATO NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 259. NATO NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 260. NATO NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 261. NATO NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 262. NATO NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 263. NATO NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. NATO NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 265. NATO NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 266. NATO NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 267. NATO NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 268. NATO NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 286. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 287. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 288. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 289. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 290. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 292. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 293. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 294. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 295. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 299. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 300. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 301. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 302. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 303. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 304. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 305. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 306. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 307. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 308. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 312. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 313. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 314. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 315. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 316. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 317. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 318. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 319. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 320. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 321. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 335. GERMANY NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 336. GERMANY NEUROREHABILITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. GERMANY NEUROREHABILITATION DEVICES MARKET SIZE, BY BIOFEEDBACK SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 338. GERMANY NEUROREHABILITATION DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 339. GERMANY NEUROREHABILITATION DEVICES MARKET SIZE, BY FUNCTIONAL ELECTRICAL STIMULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 340. GERMANY NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROMODULATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 341. GERMANY NEUROREHABI